Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Galesburg Cottage Hospital
391
mi
from 43215
Galesburg, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Galesburg Cottage Hospital
391
mi
from 43215
Galesburg, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mason District Hospital
371
mi
from 43215
Havana, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mason District Hospital
371
mi
from 43215
Havana, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Hopedale Medical Complex
339
mi
from 43215
Hopedale, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Hopedale Medical Complex
339
mi
from 43215
Hopedale, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Joliet Oncology-Hematology Associates, Limited - West
288
mi
from 43215
Joliet, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Joliet Oncology-Hematology Associates, Limited - West
288
mi
from 43215
Joliet, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
McDonough District Hospital
404
mi
from 43215
Macomb, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
McDonough District Hospital
404
mi
from 43215
Macomb, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
405
mi
from 43215
Moline, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
405
mi
from 43215
Moline, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
404
mi
from 43215
Moline, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
404
mi
from 43215
Moline, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
BroMenn Regional Medical Center
316
mi
from 43215
Normal, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
BroMenn Regional Medical Center
316
mi
from 43215
Normal, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Community Cancer Center
316
mi
from 43215
Normal, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Community Cancer Center
316
mi
from 43215
Normal, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
OSF Saint Elizabeth Medical Center
319
mi
from 43215
Ottawa, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
OSF Saint Elizabeth Medical Center
319
mi
from 43215
Ottawa, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Oncology Hematology Associates of Central Illinois, PC - Ottawa
319
mi
from 43215
Ottawa, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Oncology Hematology Associates of Central Illinois, PC - Ottawa
319
mi
from 43215
Ottawa, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Treatment Center at Pekin Hospital
350
mi
from 43215
Pekin, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Treatment Center at Pekin Hospital
350
mi
from 43215
Pekin, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Proctor Hospital
350
mi
from 43215
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Proctor Hospital
350
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Illinois Oncology Research Association
352
mi
from 43215
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Illinois Oncology Research Association
352
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Oncology Hematology Associates of Central Illinois, PC - Peoria
349
mi
from 43215
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Oncology Hematology Associates of Central Illinois, PC - Peoria
349
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Methodist Medical Center of Illinois
349
mi
from 43215
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Methodist Medical Center of Illinois
349
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
OSF St. Francis Medical Center
349
mi
from 43215
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
OSF St. Francis Medical Center
349
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Illinois Valley Community Hospital
333
mi
from 43215
Peru, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Illinois Valley Community Hospital
333
mi
from 43215
Peru, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Perry Memorial Hospital
350
mi
from 43215
Princeton, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Perry Memorial Hospital
350
mi
from 43215
Princeton, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Margaret's Hospital
337
mi
from 43215
Spring Valley, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Margaret's Hospital
337
mi
from 43215
Spring Valley, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Carle Cancer Center at Carle Foundation Hospital
274
mi
from 43215
Urbana, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Carle Cancer Center at Carle Foundation Hospital
274
mi
from 43215
Urbana, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
274
mi
from 43215
Urbana, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
274
mi
from 43215
Urbana, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Francis Hospital and Health Centers - Beech Grove Campus
163
mi
from 43215
Beech Grove, IN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Francis Hospital and Health Centers - Beech Grove Campus
163
mi
from 43215
Beech Grove, IN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Saint Anthony Memorial Health Centers
234
mi
from 43215
Michigan City, IN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Saint Anthony Memorial Health Centers
234
mi
from 43215
Michigan City, IN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Reid Hospital & Health Care Services
99
mi
from 43215
Richmond, IN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Reid Hospital & Health Care Services
99
mi
from 43215
Richmond, IN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
McFarland Clinic, PC
569
mi
from 43215
Ames, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
McFarland Clinic, PC
569
mi
from 43215
Ames, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
405
mi
from 43215
Bettendorf, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
405
mi
from 43215
Bettendorf, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Capitol Hospital
563
mi
from 43215
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Capitol Hospital
563
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
565
mi
from 43215
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
565
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
565
mi
from 43215
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
565
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
565
mi
from 43215
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
565
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Medical Oncology and Hematology Associates at Mercy Cancer Center
566
mi
from 43215
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Medical Oncology and Hematology Associates at Mercy Cancer Center
566
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
566
mi
from 43215
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
566
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
John Stoddard Cancer Center at Iowa Lutheran Hospital
564
mi
from 43215
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
John Stoddard Cancer Center at Iowa Lutheran Hospital
564
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Cancer Center at Mercy Medical Center - North Iowa
569
mi
from 43215
Mason City, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Cancer Center at Mercy Medical Center - North Iowa
569
mi
from 43215
Mason City, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology Associates, LLP
715
mi
from 43215
Sioux City, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology Associates, LLP
715
mi
from 43215
Sioux City, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Medical Center - Sioux City
716
mi
from 43215
Sioux City, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Medical Center - Sioux City
716
mi
from 43215
Sioux City, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Luke's Regional Medical Center
716
mi
from 43215
Sioux City, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Luke's Regional Medical Center
716
mi
from 43215
Sioux City, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Chanute
687
mi
from 43215
Chanute, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Chanute
687
mi
from 43215
Chanute, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Dodge City
925
mi
from 43215
Dodge City, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Dodge City
925
mi
from 43215
Dodge City, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - El Dorado
756
mi
from 43215
El Dorado, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - El Dorado
756
mi
from 43215
El Dorado, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Kingman
827
mi
from 43215
Kingman, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Kingman
827
mi
from 43215
Kingman, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Southwest Medical Center
986
mi
from 43215
Liberal, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Southwest Medical Center
986
mi
from 43215
Liberal, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Newton
778
mi
from 43215
Newton, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Newton
778
mi
from 43215
Newton, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Parsons
683
mi
from 43215
Parsons, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Parsons
683
mi
from 43215
Parsons, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Pratt
860
mi
from 43215
Pratt, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Pratt
860
mi
from 43215
Pratt, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Salina
782
mi
from 43215
Salina, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Salina
782
mi
from 43215
Salina, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Wellington
797
mi
from 43215
Wellington, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Wellington
797
mi
from 43215
Wellington, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Associates in Womens Health, PA - North Review
782
mi
from 43215
Wichita, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Associates in Womens Health, PA - North Review
782
mi
from 43215
Wichita, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Medical Arts Tower
781
mi
from 43215
Wichita, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Medical Arts Tower
781
mi
from 43215
Wichita, KA
Click here to add this to my saved trials